Drug Shortage Report for RETIN-A
Report ID | 170140 |
Drug Identification Number | 00443816 |
Brand name | RETIN-A |
Common or Proper name | RETIN-A |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | TRETINOIN |
Strength(s) | 0.025% |
Dosage form(s) | GEL |
Route of administration | TOPICAL TOPICAL |
Packaging size | 30g |
ATC code | D10AD |
ATC description | ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2022-09-15 |
Estimated end date | 2022-09-27 |
Actual end date | 2022-09-27 |
Shortage status | Resolved |
Updated date | 2022-09-28 |
Company comments | waiting QA release |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-09-28 | English | Compare |
v4 | 2022-09-27 | French | Compare |
v5 | 2022-09-27 | French | Compare |
v3 | 2022-09-27 | English | Compare |
v2 | 2022-09-23 | French | Compare |
v1 | 2022-09-23 | English | Compare |
Showing 1 to 6 of 6